WHO warns of drug-resistant strains of gonorrhea

NewsGuard 100/100 Score

"Drug-resistant strains of gonorrhea have spread to countries across the world, the U.N. health agency said on Wednesday, and millions of patients may run out of treatment options unless doctors catch and treat cases earlier," Reuters reports (Kelland, 6/6). "Already several countries, including Australia, France, Japan, Norway, Sweden and the United Kingdom are reporting cases of resistance to cephalosporin antibiotics -- the last treatment option against gonorrhea," a WHO press release states (6/6).

"'This organism has basically been developing resistance against every medication we've thrown at it,' said Dr. Manjula Lusti-Narasimhan, a scientist in the agency's department of sexually transmitted diseases," according to the Associated Press. "In a couple of years it will have become resistant to every treatment option we have available now," she added, the news service notes. The WHO "is urging governments and doctors to step up surveillance of antibiotic-resistant gonorrhea, a bacterial infection that can cause inflammation, infertility, pregnancy complications and, in extreme cases, lead to maternal death," the AP writes (6/6).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression